www.StockMarketingInc.com: Sign Up For The Hottest Newsletter!! Don't Wait!! Act Now"" BRYN,AVOE,GETA,JEDM,BSPM,AMNP

(PINKSHEETS: BRYN - Bryn Resources, Inc.)

(OTCBB: AVOE - Avro Energy, Inc.)

(OTCBB: GETA - Genta Incorporated)

(PINKSHEETS: JEDM - Jedi Mind, Inc.)

(OTCBB: BSPM - Biostar Pharmaceuticals, Inc.)

(OTCBB: AMNP - American Sierra Gold Corp.)

www.StockMarketingInc.com

To sign up for our free Profiles & Alerts :: visit http://www.StockMarketingInc.com

email us!! info@StockMarketingInc.com or call 1-866-583-8960

------------------------------------------------------------------------------------------------------------------------------------------------------------

(PINKSHEETS: BRYN - Bryn Resources, Inc.)

LATEST NEWS!!

BRYN Resources Inc. Comments on Recent Share Price Activity

TORONTO, Nov 09, 2009 -- BRYN Resources Inc (PINKSHEETS: BRYN | Quote | Chart | News | PowerRating) (PINKSHEETS: BRYN.PK). The company has received numerous shareholder inquiries in regards to recent activity in the company's share price. BRYN Resources Inc. has been actively discussing potential acquisitions with investment bankers, intermediaries and mining company principals in the United States and Canada.

The goal of these acquisitions is to develop a portfolio of properties that have high gold exploration potential and/or production potential. Management of BRYN Resources Inc. is proactively involved in closing a production deal at the time of this press release. We expect to be able to update our shareholders in the next ten business days or earlier.

BRYN Resources Inc. is committed to preserving the integrity of our shareholders interest in the company and to that end we have sought out acquisitions which will enhance and add to the value of the company. If we are able to close this production deal, we expect the cash flow to be in the several millions of dollars.

Lastly, we expect to be able to update shareholders about some new management and board appointments that will help the company move forward with the above mentioned goals. This new personnel will be mandated to integrate all new acquisitions and fast track the up listing of the company to a more senior exchange.

------------------------------------------------------------------------------------------------------------------------------------------------------------

(OTCBB: AVOE - Avro Energy, Inc.)

LATEST NEWS!!

Avro Energy Commences Workover Operations on Arkansas Deep Oil Well

VIVIAN, La., Nov 9, 2009 -- Avro Energy, Inc. (OTCBB:AVOE) is pleased to announce that it has begun workover operations on the RM Collins deep oil well near Mandeville, Arkansas. This well is currently producing from the deep Smackover Formation.

As previously disclosed, the South Arkansas Deep Well acquisition meets the Company's model of acquiring deeper oil and gas production, with the ultimate goal of becoming a junior oil and gas exploration and production company.

About the South Arkansas Deep Wells These eleven producible deep oil wells are located in South Arkansas. Seven of these wells are currently in production with the other four capable of production after workover operations. In addition, the Company will acquire three disposal wells with this package. The deepest of these wells produces from the Smackover formation at 7800 feet, which fits with the Company's plan to look at deeper horizons for zones capable of larger production. The producing wells are productive from the Rodessa, Paluxy, Pettit, Smackover, and Tuscaloosa Formations.

The Company is continuing to negotiate on other deep projects in the ArkLaTex region of Louisiana and will keep its shareholders updated.

About the ArkLaTex Oil-Producing Region The ArkLaTex is a U.S. socio-economic region where Arkansas, Louisiana, Texas, and Oklahoma intersect. The region is centered on the Shreveport/Bossier metropolitan area in Northwest Louisiana. The region's history is heavily linked with the oil industry. The geology associated with the deposition of sediments from the Mississippi River, in particular, makes this area an abundant source for the oil and gas industries, which leads to the high levels of oil production within the region.

About Avro Energy, Inc.

Avro Energy Inc. is an independent energy company engaged in the acquisition, exploration and development of oil and natural gas properties in North America. Avro's objective is to seek out and develop opportunities in the oil and natural gas sectors that represent low risk opportunities for the Company and its shareholders. In addition, Avro aims to seek larger projects that can be developed and produced with Joint Venture partners. More information about the Company is available at its corporate website at http://www.avroenergy.com. Alternatively, shareholders can call the Company directly at 318-734-4737 or send an email to avroenergy@gmail.com.

------------------------------------------------------------------------------------------------------------------------------------------------------------

(OTCBB: GETA - Genta Incorporated)

LATEST NEWS!!

Genta Incorporated to Present at the Lazard Capital Markets Sixth Annual Healthcare Conference

[webcast]

BERKELEY HEIGHTS, N.J., Nov 10, 2009 -- Genta Incorporated (OTCBB: GETA) announced that the Company's Chairman and Chief Executive Officer, Dr. Raymond P. Warrell, Jr., will provide a company overview at the Lazard Capital Markets 6th Annual Healthcare Conference on Wednesday, November 18th at 3:15 pm EST. The conference will be held at The St. Regis Hotel in New York City.

The presentation will be webcast and accessible at the Investor Relations section of the Company's website at: http://www.genta.com/investorrelation/events.html. The presentation will be archived for 30 days.

About Genta Genta Incorporated is a biopharmaceutical company with a diversified product portfolio that is focused on delivering innovative products for the treatment of patients with cancer. Two major programs anchor the Company's research platform: DNA/RNA-based Medicines and Small Molecules. Genasense(R) (oblimersen sodium) Injection is the Company's lead compound from its DNA/RNA Medicines program. Genasense is being developed as an agent that may enhance the effectiveness of current anticancer therapy. The leading drug in Genta's Small Molecule program is Ganite(R) (gallium nitrate injection), which the Company is exclusively marketing in the U.S. for treatment of symptomatic patients with cancer related hypercalcemia that is resistant to hydration. The Company has developed G4544, an oral formulation of the active ingredient in Ganite, which has recently entered clinical trials as a potential treatment for diseases associated with accelerated bone loss. The Company is also developing tesetaxel, a novel, orally absorbed, semi-synthetic taxane that is in the same class of drugs as paclitaxel and docetaxel. Ganite and Genasense are available on a "named-patient" basis in countries outside the United States. For more information about Genta, please visit our website at: www.genta.com.

------------------------------------------------------------------------------------------------------------------------------------------------------------

(PINKSHEETS: JEDM - Jedi Mind, Inc.)

LATEST NEWS!!

Call Of Duty: Modern Warfare 2 Expected to Earn $500 Million in First Week

CARDIFF, Calif., Nov 10, 2009 -- Jedi Mind, Inc. (Pink Sheets: JEDM), announces this holiday season's biggest entertainment blockbuster will likely be a video game called Call Of Duty: Modern Warfare 2, which is anticipated to be released today. It could easily rake in more than last year's record of $155 million for opening weekend of the movie, "The Dark Knight." The video game market is showing no signs of slowing down, with fans expected to spend at least half a billion dollars on the game in the first week. If so, this would be the most successful video game release in history and possibly the biggest entertainment launch ever.

Jedi Mind plans to launch their first video game this month using thought controlled technology, whereby the players operate the game with the power of their mind. This will be the first of many games planned to be launched by the Company. "We are in the right place at the right time," stated Brent Fouch, CEO, who sees Jedi Mind as a ground floor opportunity for investors to be involved in the multi-billion dollar video game industry.

Jedi Mind, Inc. develops software for thought controlled technologies, allowing the user to interact with the computer and other machines through the power of the mind. The technology involves the use of a wireless headset, developed by our strategic partner, which detects brainwaves on both the conscious and non-conscious level. This revolutionary neural processing technology makes it possible for computers to interact directly with the human brain. The Company plans to create multiple video games that are controlled by the power of your mind, as well as develop medical applications for the disabled.

WWW.JediMindInc.com

------------------------------------------------------------------------------------------------------------------------------------------------------------

(OTCBB: BSPM - Biostar Pharmaceuticals, Inc.)

LATEST NEWS!!

Biostar Pharmaceuticals, Inc. to Host Fiscal Year 2009 Third Quarter Earnings Conference Call on Thursday, November 12, 2009 at 9:30 a.m. ET

XIANYANG, China, Nov 09, 2009 -- Biostar Pharmaceuticals, Inc. (OTC Bulletin Board: BSPM) ("Biostar" or "the Company"), a Xianyang-based developer, manufacturer and supplier of pharmaceutical products and medical nutrients addressing a variety of diseases and conditions, today announced that management will hold a conference call to discuss its 2009 third quarter performance at 9:30 a.m. ET on Thursday, November 12, 2009. Financial results will be released on November 11, 2009 after the market closes.

Interested parties may access the call by dialing +1-888-549-7704 from within the United States, or +1-480-629-9857 if calling internationally. The conference ID is 4182017. It is advisable to dial in approximately 5-10 minutes prior to the start of the call.

This call is being web cast by ViaVid Broadcasting and can be accessed at ViaVid's website at http://www.viavid.net or at the following link: http://viavid.net/dce.aspx?sid=00006CE5 . To access the web cast, you will need to have the Windows Media Player on your desktop. For the free download of the Media Player please visit: http://www.microsoft.com/windows/windowsmedia/en/download/default.asp .

About Biostar Pharmaceuticals, Inc.

Biostar Pharmaceuticals, Inc., through its wholly-owned subsidiary in China, develops, manufactures and markets pharmaceutical and medical nutrient products for a variety of diseases and conditions. The Company's most popular product is its Xin Ao Xing Oleanolic Acid Capsule, an over-the-counter ("OTC") medicine for chronic hepatitis B, a disease affecting approximately 10% of the Chinese population. In addition to its hepatitis product, Biostar manufactures two broad-based OTC products, two prescription-based pharmaceuticals and ten nutrients. The Company has adopted international standards and is in the process of applying for three patents.

------------------------------------------------------------------------------------------------------------------------------------------------------------

(OTCBB: AMNP - American Sierra Gold Corp.)

LATEST NEWS!!

American Sierra Gold Corp. Signs LOI to Acquire Copper-Gold-Silver Project

RENO, NV, Nov 10, 2009 -- American Sierra Gold Corp. (OTCBB: AMNP), an independent gold exploration company headquartered in Reno, Nevada, is pleased to announce that it has signed a Letter of Intent to acquire a 100% interest in the Carol Project located in southern Sonora State, Mexico.

The Carol Project The Carol property is comprised of six mineral concessions that cover 1,868 acres. It is located approximately 2 miles north of Frontera Copper Corp.'s Piedras Verdes copper porphyry mine, which is currently producing and has a reported proven and probable reserve of 191 million tonnes grading 0.36% copper.

The property is host to three distinct mineralized targets: the bulk tonnage-style Balde copper-zinc-gold-silver skarns, the Escondida shear zone and high-grade epithermal vein-hosted silver and gold.

The Balde Norte skarn is exposed over an area at least 700m long by 180m across, whereas the larger Balde Sur skarn target is exposed over an area that measures 1,100m by 400m. Small gambusino-style workings occur at the northern end of the Balde Sur target where sampling returned 8 metres grading 1.62% copper, 4.18% zinc and 10.0 g/t silver.

In the centre of the property is the La Escondida zone where sampling returned 8 metres averaging 1.10 g/t Au, 21.23 g/t Ag as well as 2.25% Cu. This zone is open both along strike and to depth. In 2008, a new gold zone discovered at Carol uncovered 20 metres averaging 0.66 g/t gold that is open in all directions. The highest gold assay received was 2.24 g/t.

"The Carol project is a valuable addition to our project portfolio. It has an exciting potential to host a bulk tonnage copper-gold-silver deposit and the property's infrastructure is excellent. A trenching program carried out in 2008 showed that the property contains multiple targets with average grades greater than 1% copper, 1% zinc, 6 g/t silver and 0.3 g/t gold," commented Wayne Gruden, CEO of American Sierra.

"Several of the target zones remain open in at least one direction. This is significant in that there is the potential, with additional exploratory work, to show mineralization over much wider widths. We will initiate the due diligence process as soon as possible and expect to sign a final agreement in the near future," added Mr. Gruden.

Under the terms of the Letter of Intent, to earn a 100% interest American Sierra will be required to pay the vendor US$50,000, spend US$600,000 on exploration expenditures over a three year period and issue 500,000 shares during the same period.

Correction to Press Release Dated September 30, 2009 on Urique Project Our news release of September 30, 2009 reported one sampling result on the Urique South Zone that was incorrect. Please note that the correct local bonanza grade gold found on this zone was 10.6 g/t (grams per ton) gold.

------------------------------------------------------------------------------------------------------------------------------------------------------------

About StockMarketingInc.com StockMarketingInc.com is a website that profiles stocks of interest. We are not licensed brokers or financial consultants. The information here is believed to be reliable, but not guaranteed to be accurate by StockMarketingInc.com. Please be advised that the information contained may or may not be complete and is solely for informational purposes only. This is not to be construed as an offer to sell, hold or the solicitation of an offer to buy. Investors are encouraged to seek opinions by their registered brokers or financial advisors after extensive due diligence is performed.

CONTACT: StockMarketingInc.com
e-mail: info@StockMarketingInc.com
Tel: +1 866 583 8960

((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.

For full details on (BRYN) BRYN. (BRYN) has Short Term PowerRatings at TradingMarkets. Details on (BRYN) Short Term PowerRatings is available at This Link.